Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that it received a $5 million milestone payment from Ipsen, triggered…
– Dr. Kraus to lead newly-created Neurosciences Therapy Area – Zhijian Chen, Ph.D., named Strategic Scientific Advisor BEIJING & DURHAM,…
As more health systems adopt company’s medically integrated care model, patients nationwide are benefiting from integrated specialty pharmacy care ATLANTA–(BUSINESS…
Immune response data from its HOT Lung program expected early 2020 PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology…
CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics, a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific…
BRIDGEWATER, NJ.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration approval…
NEW YORK–(BUSINESS WIRE)–Piper Jaffray Companies (NYSE: PJC), a leading investment bank and institutional securities firm, will host its 31st annual…
Closing conditions waived – Amended & Restated Partnership Agreement is now closed Acerus-Aytu jointly led commercial effort behind NATESTO® in…
Closing conditions waived – Amended & Restated Partnership Agreement is now closed Acerus-Aytu jointly led commercial effort behind NATESTO® in…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a biotechnology company focused on drugging the human immune synapse to treat human diseases, will present…